Cancer Immunology – News and Features
News
Novel Cancer Therapy Activates Only Near Tumors, Reducing Side Effects
Researchers at UC San Francisco developed SNIPRs, sensors that activate engineered cells only in the tumor environment, offering targeted cancer treatment. When tested in mice, the SNIPR-equipped cells attacked only tumor cells.
News
CAR T-Cell Therapy Fights Lethal Childhood Brain Cancer in Trial
A Stanford Medicine trial has shown success with CAR-T cell therapy in shrinking deadly childhood brain tumors. For one patient, tumor traces disappeared completely, marking a promising development in treating diffuse intrinsic pontine glioma (DIPG).
News
CAR T-Cell Therapy Attacks Brain Tumors From Multiple Angles
Researchers at the University of Basel have developed CAR T-cells that target glioblastoma, a notoriously aggressive brain cancer. This approach not only attacks tumor cells directly but also neutralizes the tumor’s supportive microenvironment.
News
Lab-Grown Model Reveals Weakened Immune Response in Cancer Patients
Tiny lab-grown models of human immune systems are helping researchers understand why cancer patients struggle to fight infections.
News
Antibody Developed With Potential To Treat Several Types of Cancer
Researchers developed a 3-in-1 antibody that targets tumors, delivers treatment, and activates immune cells to enhance T-cell response. The customizable, scalable method shows potential for safer and quicker precision cancer therapy.
News
Virtual Drug Screening Identifies Candidates for Cancer Immunotherapy
Researchers at Weill Cornell used virtual screening to find small molecules targeting cancer checkpoints, showing promise as alternatives to monoclonal antibody treatments. The study identified compounds MG-T-19 and MG-V-53.
News
Cancer-Killing Virus Shows Promise Against Aggressive Brain Tumors
Researchers have engineered an adenovirus to selectively target and kill aggressive brain cancer cells, which has shown promise in a phase 1, dose-escalation study.
News
A New Target for Colorectal Cancer Treatment
USC researchers have found that targeting CD47, a protein enabling cancer to evade immune cells, could enhance colorectal cancer treatments. Blocking CD47, combined with traditional therapies, could stimulate immune responses against tumors.
News
Drug Combination Flags Brain Tumor Cells for Immune System Attack
In a cell-based study, researchers have forced glioblastoma cells to display immune system targets, making them visible to the immune system and vulnerable to immunotherapies.
News
AI Tool Identifies Better Antibody Therapies
Georgia Tech researchers created AF2Complex, a deep-learning tool that predicts antibody interactions with proteins, enhancing immunotherapy development. The model accurately identified effective antibodies against Covid-19.
Advertisement